Int. J. Mol. Sci. 2013, 14(1), 273-285; doi:10.3390/ijms14010273
Article

Antitumor Effects of Rapamycin in Pancreatic Cancer Cells by Inducing Apoptosis and Autophagy

1,†,* email, 2,†email, 1,†email, 1email, 1email, 1email, 1email, 1email and 3,* email
Received: 7 November 2012; in revised form: 2 December 2012 / Accepted: 12 December 2012 / Published: 21 December 2012
(This article belongs to the Special Issue Signalling Molecules and Signal Transduction in Cells)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Rapamycin (Rapa), an inhibitor of mammalian target of Rapamycin (mTOR), is an immunosuppressive agent that has anti-proliferative effects on some tumors. This study aims to investigate the effects of Rapa suppressing proliferation of pancreatic carcinoma PC-2 cells in vitro and its molecular mechanism involved in antitumor activities. MTT assays showed that the inhibition of proliferation of PC-2 cells in vitro was in a time- and dose-dependent manner. By using transmission electron microscopy, apoptosis bodies and formation of abundant autophagic vacuoles were observed in PC-2 cells after Rapa treatment. Flow cytometry assays also showed Rapa had a positive effect on apoptosis. MDC staining showed that the fluorescent density was higher and the number of MDC-labeled particles in PC-2 cells was greater in the Rapa treatment group than in the control group. RT-PCR revealed that the expression levels of p53, Bax and Beclin 1 were up-regulated in a dose-dependent manner, indicating that Beclin 1 was involved in Rapa induced autophagy and Rapa induced apoptosis as well as p53 up-regulation in PC-2 cells. The results demonstrated that Rapa could effectively inhibit proliferation and induce apoptosis and autophagy in PC-2 cells.
Keywords: pancreatic carcinoma; rapamycin; mTOR; anti-tumor; apoptosis; autophagy
PDF Full-text Download PDF Full-Text [843 KB, Updated Version, uploaded 19 June 2014 04:36 CEST]
The original version is still available [1184 KB, uploaded 19 June 2014 04:36 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Dai, Z.-J.; Gao, J.; Ma, X.-B.; Kang, H.-F.; Wang, B.-F.; Lu, W.-F.; Lin, S.; Wang, X.-J.; Wu, W.-Y. Antitumor Effects of Rapamycin in Pancreatic Cancer Cells by Inducing Apoptosis and Autophagy. Int. J. Mol. Sci. 2013, 14, 273-285.

AMA Style

Dai Z-J, Gao J, Ma X-B, Kang H-F, Wang B-F, Lu W-F, Lin S, Wang X-J, Wu W-Y. Antitumor Effects of Rapamycin in Pancreatic Cancer Cells by Inducing Apoptosis and Autophagy. International Journal of Molecular Sciences. 2013; 14(1):273-285.

Chicago/Turabian Style

Dai, Zhi-Jun; Gao, Jie; Ma, Xiao-Bin; Kang, Hua-Feng; Wang, Bao-Feng; Lu, Wang-Feng; Lin, Shuai; Wang, Xi-Jing; Wu, Wen-Ying. 2013. "Antitumor Effects of Rapamycin in Pancreatic Cancer Cells by Inducing Apoptosis and Autophagy." Int. J. Mol. Sci. 14, no. 1: 273-285.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert